Atomwise pursues 15 collaborations for COVID-19 treatments

By The Science Advisory Board staff writers

May 22, 2020 -- Small molecule drug discovery company Atomwise has announced it is collaborating with 15 institutions to develop broad-spectrum therapies for coronaviruses, including the novel coronavirus responsible for COVID-19.

Participating institutions include the following:

  • University of Mannitoba
  • Columbia University
  • University of Connecticut
  • University of Kentucky
  • University of South Australia
  • University of Texas Medical Branch Health
  • Jazan University
  • Dana-Farber Cancer Institute
  • University of Texas Health Science Center at San Antonio
  • University of Toledo

Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.